About DRMRC

Where Science, Data & Ethics Converge

DRMRC is a modern medical research organisation that pairs rigorous laboratory practice with advanced analytics. We build partnerships across industry and academia to help discover, validate, and deliver health innovations responsibly.

Evidence-firstEthical by designAudit-ready
DRMRC laboratory setting
Our Purpose

Advancing medicine with transparency and measurable impact

We exist to shorten the distance between scientific insight and patient benefit. Our teams orchestrate research, inspections, and sourcing with clear governance, explainable analytics, and meticulous documentation.

01

Science Rigor

Methodical design, reproducible results, and continuous peer review.

02

People First

Respect for participants, researchers, and communities in every decision.

03

Trust & Traceability

Every step is recorded, auditable, and aligned to ethical frameworks.

About Us

DE ROTHSCHILD MEDICAL AND RESEARCH CENTRE (DRMRC.COM) L.P.

DE ROTHSCHILD MEDICAL AND RESEARCH CENTRE (DRMRC.COM) L.P. is a distinguished medical research and biotechnology institution, established in 2012 and headquartered at 108 Hatherley Court, Hatherley Grove, London, W2 5RG, United Kingdom. Founded by Dr. Vladimir Levy (MD, PhD), a visionary medical doctor and research scientist, the Centre was created with the mission of advancing global health through cutting-edge medical research and pharmaceutical innovation.

As a limited liability partnership, DRMRC has built a reputable presence in the global medical landscape, with more than a decade of collaboration with government bodies, private institutions, and international research networks. Our core mission is the identification, validation, and clinical trial testing of potent biomaterials—natural or synthetic substances with proven pharmacological properties—sourced from certified suppliers and partners around the world.

These biomaterials undergo rigorous clinical evaluations at DRMRC and are then supplied to pharmaceutical manufacturers to support the development of life-saving drugs, particularly those targeting terminal and hard-to-treat diseases such as cancer, autoimmune disorders, neurodegenerative conditions, and rare infections.

Over the years, DRMRC has evolved into a leading commercial supplier and strategic research partner for pharmaceutical and biotech companies worldwide. Our commitment to excellence in research ethics, quality assurance, and innovative solutions has earned us prestigious industry recognitions and accolades, affirming our impact on the global healthcare ecosystem.

With a vision grounded in scientific integrity, global collaboration, and the advancement of human health, DE ROTHSCHILD MEDICAL AND RESEARCH CENTRE continues to pave the way for the next generation of therapeutic discoveries—bringing hope and healing to millions around the world.

DRMRC team
Founded2012 (London, United Kingdom)
FounderDr. Vladimir Levy (MD, PhD)
Legal FormLimited Partnership (L.P.)
Head Office108 Hatherley Court, Hatherley Grove, London, W2 5RG
FocusIdentification, validation & clinical testing of potent biomaterials
Therapeutic AreasCancer, autoimmune, neurodegenerative, rare infections
Research collaboration
What We Do

From protocol to insight—joined-up research support

  • Clinical & translational research coordination
  • Independent inspection and verification
  • Global sourcing of clinical-grade biomaterials
  • AI-assisted evidence review & risk triage
  • Post-study reporting & knowledge transfer
Methods & Technology

Human expertise, amplified by transparent AI

Our internal workflows use explainable models to highlight outliers, cross-check laboratory data, and rank evidence strength. Algorithms never replace expert judgement—they make it faster and easier to act on.

  • Supplier dossier triage & CoA consistency checks
  • Deviation and safety signal detection across sites
  • Contextual literature scans mapped to protocols
  • Secure data handling with privacy-preserving aggregation
Quality and inspection
Our Journey

How our approach took shape

Origins in lab practice
Built by researchers who wanted reproducibility and clear hand-offs between teams.
Independent verification
Added third-party inspection to remove ambiguity in complex collaborations.
Data-informed operations
Introduced analytics to prioritise tasks and shorten review cycles.
Global collaboration
Scaled networks and governance so partners can work together with confidence.
Ethics & Governance

Doing the right work, the right way

Our governance model emphasises participant welfare, privacy, and transparency at every stage of research and procurement.

Participant dignity & informed consent
We support IRB/IEC processes and ensure clarity on benefits, risks, and data handling across all studies we coordinate.
Data responsibility
We adopt privacy-preserving techniques and least-access principles with clear audit trails.
Conflict management
Independence in inspection and transparent reporting reduce bias and maintain trust.
Environment & safety
Material handling follows validated SOPs, and logistics partners are monitored for safety and sustainability practices.
Governance & team
Who We Serve

Our Clients & Collaborators

From Big Pharma to biotech startups, we support:

Pharmaceutical manufacturers

Sourcing, inspection, and evidence support to de-risk pipelines.

Clinical trial sponsors

Protocol operations, site monitoring, and post-trial reporting.

Biomedical innovators

Special access materials, feasibility checks, and rapid iteration.

Health ministries & NGOs

Scalable programmes with ethical sourcing and transparent oversight.

Academic & institutional labs

Certified inputs, collaboration frameworks, and reproducibility support.

Inspection partners

Independent verification with shared playbooks.

Work With Us

Let’s build responsible breakthroughs

Whether you’re planning a study, auditing a supplier, or seeking certified biomaterials, our team can help you progress with confidence.

Team collaboration
Scroll to Top